Related Experiment Video
Updated: Jun 17, 2025

07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.5K
Exploring the correlation between gut microbiota and benign gastric tumors: A Mendelian randomization study
1Department of Hematology and Oncology Laboratory, The Central Hospital of Shaoyang, Shaoyang, Hunan Province, China.
Medicine
|August 9, 2024
Summary
This study reveals specific gut bacteria linked to benign gastric tumors. Certain bacteria increase risk, while others offer protection, suggesting gut microbiota modulation as a potential prevention strategy.
Area of Science:
- Gastroenterology
- Microbiology
- Genetics
Background:
- Emerging research indicates a connection between stomach and gut microbiota.
- Understanding this link is crucial for identifying novel therapeutic targets for gastric conditions.
Purpose of the Study:
- To investigate the association between gut microbiota composition and benign gastric tumors using Mendelian randomization (MR).
Main Methods:
- Utilized genome-wide association studies (GWAS)-aggregated data for 211 gut microbes and benign gastric lesions.
- Employed multiple MR statistical methods (IVW, weighted median, MR-Egger, etc.) for robust analysis.
- Applied leave-one-out analysis, MR-PRESSO, and MR-Egger intercepts to ensure result validity and mitigate pleiotropy.
Main Results:
- Positive associations found between benign gastric tumors and Porphyromonadaceae, Bacilli, Lactobacillaceae, and Oxalobacteraceae.
- Negative associations (protective effect) observed with Pasteurellaceae and Peptococcaceae.
- Significant odds ratios (OR) and p-values quantify the risk or protective effect of specific microbial families/classes.
Conclusions:
- Gut microbiota composition significantly influences the risk of developing benign gastric tumors.
- Specific bacterial taxa, such as Porphyromonadaceae and Pasteurellaceae, play key roles in gastric tumor development or prevention.
- Targeting and regulating gut microbiota presents a promising avenue for reducing the incidence of benign gastric tumors.

